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Our knowledge about the neurobiology of suicide is limited. It has been proposed that suicidal
behavior generally requires biological abnormalities concomitant with the personality trait of
impulsivity/aggression, besides an acute psychiatric illness or psychosocial stressor. We
investigated fronto-limbic anatomical brain abnormalities in suicidal and non-suicidal adult
female patients with unipolar depression. Our sample consisted of seven suicidal unipolar
patients, 10 non-suicidal unipolar patients and 17 healthy female comparison subjects. The
criterion for suicidality was one or more documented lifetime suicide attempts. A 1.5T GE
Signa Imaging System running version Signa 5.4.3 software was used to acquire the magnetic
resonance imaging images. All anatomical structures were measured blindly, with the
subjects’ identities and group assignments masked. We used analysis of covariance with
age and intracranial volume as covariates and the Tukey–Kramer procedure to compare
suicidal patients, non-suicidal patients and healthy comparison subjects. Suicidal patients had
smaller right and left orbitofrontal cortex gray matter volumes compared with healthy
comparison subjects. Suicidal patients had larger right amygdala volumes than non-suicidal
patients. Abnormalities in the orbitofrontal cortex and amygdala in suicidal patients may
impair decision-making and predispose these patients to act more impulsively and to attempt
suicide.
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Introduction
The risk for suicide is 10–20 times higher in people
with mood disorders than in the general population1
and our knowledge about the neurobiology of suicide
is still limited. Although suicide is a potentially
preventable cause of death, efforts to reduce suicide
rates have had minimal success. The clinical markers
of patients at high risk for suicide may detect most
patients who will commit suicide, but may also be
found in a large number of patients who will never
commit suicide.2 Understanding the neural correlates
of suicidal behavior may be helpful in reducing
suicide rates in major depression and other psychia-
tric disorders.
Serotonergic and noradrenergic abnormalities in
regions of the prefrontal cortex, as well as the dorsal
raphe nucleus and locus ceruleous are implicated in
suicide. Neurochemical studies show that there is
serotonin hypofunction in suicide victims, there are
fewer presynaptic serotonin transporter binding sites
and more post-synaptic serotonin receptors in their
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prefrontal cortex.3,4 Post-mortem studies3 as well as
in vivo studies5 demonstrate that reduced serotoner-
gic activity in cerebrospinal fluid is associated with
increased suicide risk. It has been proposed that
suicidal behavior generally requires an acute psy-
chiatric illness or psychosocial stressor, a predispos-
ing factor (such as the personality trait of impulsivity/
aggression) and concomitant biological abnormal-
ities.6 Impulsivity and a disturbed regulation of
anxiety or aggression may represent risk factors for
suicidal behavior that cut across diagnostic bound-
aries.7,8 Tebartz van Elst et al.9–11 proposed that a dual
brain pathology might be responsible for the hyper-
arousal and dyscontrol states seen in patients
with impulsivity and affective-aggressive episodes.
According to this proposal, abnormalities of the
amygdala result in dysfunctional arousal states, and
abnormalities of the prefrontal cortex result in
dyscontrol states.9–11
Structural magnetic resonance imaging (MRI) stu-
dies demonstrate volumetric abnormalities in the
prefrontal subregions and the limbic structures, that
is, hippocampus and amygdala, in patients with
major depressive disorder.12,13 Post-mortem studies
complement these results and indicate reduced
density and number of glial cells in the subgenual
anterior cingulate gyrus and orbitofrontal cortex,14
and amygdala15 in major depressive disorder. As
Strakowski et al.12 articulate, relatively diminished
prefrontal modulation on an anterior limbic network
may result in dysregulation of mood. Periventricular
and subcortical white matter changes disrupting
critical neuroanatomic pathways may contribute to
mood dysregulation. Unipolar patients with a history
of suicide attempt have significantly more subcortical
gray matter hyperintensities compared to unipolar
patients without a history of suicide attempt.16
Furthermore, there is a higher prevalence of periven-
tricular white matter hyperintensities in young adults
with unipolar depression and a history of a suicide
attempt17 compared to depressed young adults with-
out such a history. These findings suggest that gray
and white matter hyperintensities might represent
brain abnormalities that could be markers for higher
risk for suicide attempts.
Further work is clearly indicated to explore the
associations between neuroimaging findings and
suicidal behavior. We investigated fronto-limbic
anatomical brain abnormalities in suicidal and
non-suicidal adult female patients with unipolar
depression, with a hypothesis that suicidal patients
would have more pronounced fronto-limbic abnorm-
alities than non-suicidal ones.
Materials and methods
Our sample consisted of seven suicidal, 10 non-
suicidal female unipolar patients and 17 healthy
female controls. The University of Pittsburgh Institu-
tional Review Board approved the study protocol, and
all subjects gave written informed consent after
receiving a detailed description of the study. All 17
depressed subjects met diagnostic inclusion criteria
for Major Depressive Disorder as determined by the
Structured Clinical Interview for DSM-IV (SCID).18
All patients were medication-free for at least 2 weeks
immediately preceding the study. All subjects were
right-handed. The criterion for suicidality was one or
more documented suicide attempts. Clinical ratings
were carried out using the Hamilton Depression
Rating Scale (HDRS).19 At the time of study participa-
tion, five of the suicidal patients were depressed and
two were euthymic. Seven of the non-suicidal
patients were depressed and three were euthymic.
Exclusion criteria were any other DSM-IV axis I
comorbidity, current medical problems, history of
neurological illness, history of head trauma with loss
of consciousness, or history of substance or alcohol
abuse/dependence at any time.
We recruited healthy controls by advertisement and
assessed them with the Structured Clinical Interview
for DSM-IV, non-patient edition (SCID-NP). Exclusion
criteria included any DSM-IV axis I diagnosis, current
medical problems, history of neurological illness,
history of head trauma with loss of consciousness,
and positive history of psychiatric disorders or
suicide among first-degree relatives. Healthy controls
were matched, as a group, with unipolar patients for
age, gender and race.
Image acquisition
A 1.5T GE Signa Imaging System running version
Signa 5.4.3 software (General Electric Medical Sys-
tems, Milwaukee, WI, USA) was used to acquire the
MRI scans. A 3D gradient echo imaging (Spoiled
Gradient Recalled Acquisition, SPGR) was performed
in the coronal plane (TR = 25 ms, TE = 5 ms, nutation
angle = 401, FOV = 24 cm, slice thickness = 1.5 mm,
NEX = 1, matrix size = 256192) in order to obtain
124 images covering the entire brain.
Image analysis
All images, except for orbitofrontal cortex measure-
ments, were analyzed blindly using Scion Image for
Windows Beta-3b version on a PC workstation (Scion
Corporation Inc., Frederick, MD, USA). The orbito-
frontal cortex measures were conducted with the
BRAINS2 software, developed at the University of
Iowa Hospitals and Clinics. For the BRAINS2 tra-
cings, the images were spatially realigned, so that the
brain anterior–posterior axis was parallel to the AC-
PC line, which was horizontal in the sagittal plane,
and the interhemispheric fissure was vertical in the
axial plane. All raters, who met the inter-rater
agreement standard of intraclass correlation coeffi-
cients for each of the regions of > 0.90 versus a second
independent rater, did all anatomical measurements
with the subjects’ identity and group assignment
masked. Intracranial volumes were manually traced
and measured in the coronal plane.
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Regions-of-interest
The regions of primary interest were the orbitofrontal
cortex, cingulate, amygdala and hippocampus, be-
cause previous neuroimaging studies of depressed
patients have mainly shown anatomical and func-
tional abnormalities in these brain regions.12,13
A detailed description of the geometrical method
utilized to measure the orbitofrontal cortex is pre-
sented elsewhere.20
We started tracing the amygdala on the coronal slice
where the mammillary bodies first appeared. The
superior and lateral borders were distinguished by the
temporal lobe white matter. The inferior border was
the parahippocampal gyrus white matter. The anterior
border was the place where the amygdala gray matter
could no longer be distinguished from the rest of the
temporal lobe.21
Hippocampus tracing started on the coronal slice
where the thalamus was connected with the superior
colliculus and finished one slice before the mammil-
lary bodies appeared. The superior border was the
corona radiata, and then, going anteriorly, the ambient
cistern. The inferior border was the white matter, and
the lateral border was the inferior horn of the lateral
ventricle.21
The cingulate was divided into four sections,
anterior and posterior, right and left. All tracing of
the cingulate were performed in the coronal view.
The first slice traced was two slices anterior to the
final slice where the genu was visible. Tracing was
continued until the anterior commissure was appa-
rent, and it marked the posterior limit of the anterior
cingulate. The subsequent slice marked the anterior
border of the posterior cingulate. The final slice
measured was the one where the cerebral aqueduct
appeared within the pons.22
As exploratory analyses, we also measured the
lateral ventricles, caudate, putamen, thalamus, tem-
poral lobe, superior temporal gyrus, dorsolateral
prefrontal cortex and subgenual prefrontal cortex.
The tracing methods for these structures are pre-
sented elsewehere.23–26
Statistical analysis
All statistical analyses were conducted using the
SYSTAT (SPSS Science, Chicago, IL, USA) software,
version 8, and a 2-tailed statistical significance level
was set at P < 0.05. Length of illness, age at onset,
number of previous episodes and Hamilton Depres-
sion (Ham-D) scores were compared using Mann–
Whitney U-tests. Family history, episode type, educa-
tion status and previous antipsychotic usage were
compared using Fisher’s Exact Test. We used analysis
of covariance, adjusting for age and intracranial
volume followed by the Tukey–Kramer procedure to
compare adjusted mean structure volumes of suicidal
patients, non-suicidal patients and healthy compar-
ison women.
Results
Suicidal and non-suicidal patients did not differ in
number of previous episodes, length of illness, age at
illness onset and Ham-D scale scores (Table 1). The
education status was not different between the two
groups (P = 0.810). There were no significant differ-
ences in family history for mood disorders and
previous antipsychotic usage between suicidal and
non-suicidal patients (Pearson w2, P = 1.000 for both).
There were no significant differences among the three
groups with respect to age (mean7s.d. = 31.4713.9
year for suicidal patients; 36.577.5 year for non-
suicidal patients; and 31.378.3 year for healthy
women) (univariate analysis of variance, df = 2,31,
F = 1.042, P = 0.37).
Table 2 shows the results of the overall analysis of
covariance testing for the brain regions of primary
interest. Pairwise comparisons showed that
suicidal patients had smaller right (P = 0.01) and left
(P = 0.02) orbitofrontal cortex gray matter volumes
compared with healthy women (Figure 1). Suicidal
patients had larger right amygdala (P = 0.04) volumes
than non-suicidal patients (Figure 2). Non-suicidal
patients did not differ from healthy women on
any of the measures. The volumes of the regions of
primary interest (orbitofrontal cortex, cingulate,
amygdala and hippocampus) were not correlated
with the number of previous episodes, length of
illness and age at onset (Pearson correlations, un-
corrected, all P > 0.05).
Discussion
We compared female unipolar patients, with a history
of a documented suicide attempt and without a
history of suicide attempt and healthy women. The
Table 1 Clinical characteristics of suicidal and non-suicidal patients
Suicidal patients (n = 7) Non-suicidal patients (n = 10) P
Length of illness (years) 15.6715.0 9.7711.6 0.30
Age at onset (years) 16.074.5 26.9710.5 0.07
No. of previous episodes 18.6735.6 3.973.4 0.18
Ham-D scores 13.7710.9 10.978.0 0.62
Abbreviation: Ham-D scores, Hamilton Depression scores.
Mann–Whitney U-test, with exact significance (2-tailed).
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main findings of this analysis are that unipolar
patients with a history of a suicide attempt had
smaller right and left orbitofrontal cortex gray matter
volumes compared with healthy women, and larger
right amygdala than non-suicidal patients. The
involvement of both orbitofrontal cortex and amyg-
dala is intriguing, as these are two critical regions
involved in goal-directed behavior, judgment and
decision-making abilities that are most often impaired
in patients with unipolar depression.27,28
Table 2 Volumes (cm3) of brain regions of primary interest in suicidal and non-suicidal patients and healthy individuals
Region Suicidal patients
(n = 7)
Non-suicidal
patients (n = 10)
Healthy controls
(n = 17)
F df P
OFC, right gray 6.0671.06 6.8471.31 8.0971.46 5.793 2,29 0.008
OFC, left gray 5.3270.59 6.1071.38 7.1771.51 4.470 2,29 0.02
Amygdala, right 2.4670.29 1.9070.45 2.0870.43 3.594 2,29 0.04
Amygdala, left 2.0570.37 1.9170.44 1.9970.39 0.343 2,29 0.71
Hippocampus, right 3.3570.49 3.4770.42 3.2970.34 0.291 2,29 0.75
Hippocampus, left 3.4470.70 3.3870.43 3.3270.27 0.121 2,29 0.89
Cingulate, right
posterior
2.2070.30 2.8370.60 2.6870.60 2.916 2,29 0.07
Cingulate, right anterior 2.6670.26 3.1070.54 3.0070.56 1.538 2,29 0.23
Cingulate, left posterior 2.6370.51 2.7370.56 2.6770.43 0.205 2,29 0.82
Cingulate, left anterior 2.7370.48 2.7470.62 3.1770.52 2.126 2,29 0.14
Abbreviation: OFC, orbitofrontal cortex.
Unadjusted means and standard deviations are shown.
Figure 1 Right and left orbitofrontal cortex gray matter volumes in suicidal and non-suicidal patients and healthy women.
Note: Suicidal patients (n = 7) had smaller right (F = 5.793, df = 2,29, P = 0.008) and left (F = 4.470, df = 2,29, P = 0.02)
orbitofrontal cortex gray matter volumes compared with healthy women (n = 17).
Figure 2 Right and left amygdala volumes in suicidal and non-suicidal patients and healthy women. Note: Significant
difference between suicidal (n = 7) and non-suicidal (n = 10) patients for right amygdala volumes (F = 3.594, df = 2,29,
P = 0.04).
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Few studies have examined the volume of orbito-
frontal cortex in patients with unipolar depression.
Two studies in mid-life depression29,30 reported
smaller orbitofrontal cortex volumes in patients
compared to healthy comparison subjects. One pos-
sible explanation for this, as put forth by Bremner
et al.,29 is the glucocorticoid toxicity that occurs with
repeated episodes, although this has not been selec-
tively studied for orbitofrontal cortex. Patients with
depression have a long-lasting hyperactivity of the
corticotropin-releasing hormone (CRH) neurons, re-
sulting in increased stress responsiveness and reflect-
ing a glucocorticoid resistant state.31 Patients with
multiple episodes of depression exhibit greater
cortisol levels after CRH than first-episode depressive
patients and healthy controls,32 and there is down-
regulation of CRH receptors in the frontal cortex of
victims of suicide.33 In our analysis, although statis-
tically not significant, suicidal patients had more
previous episodes than non-suicidal patients, and
they had an earlier age of illness onset; both of which
could have led to greater glucotoxicity. It could also
be that suicidal patients have smaller orbitofrontal
cortices at birth (i.e. impaired neurodevelopment),
which predispose them to impaired decision-making
and impulsivity.
Orbitofrontal cortex plays a main role in decision-
making and predicting expected outcomes. Lower
levels of ventromedial activity are associated with
higher suicidal behavior and higher lethality of the
act.34 Our finding of smaller orbitofrontal cortex
volumes in suicidal patients complements the find-
ings of a recent study, which showed that suicide
attempters have a specific impairment in decision-
making, regardless of their affective state.35 These
authors suggest that impairment in decision-making
is associated with a susceptibility to suicidal beha-
vior, rather than a susceptibility to affective disorders.
Patients with orbitofrontal cortex and amygdala
lesions exhibit patterns of behavior often described
as impulsive, and they are often unable to adjust their
behavior appropriately to the contingencies of the
task, as seen in their performance on gambling tasks.36
Recently, a component of impulsivity called ‘lack of
premeditation’ (engaging in an act without thinking
or reflecting on its consequences) was found to be
linked to disadvantageous decision making.37 The
‘somatic marker hypothesis’ proposes that decision
making is a process that depends on emotion, and
that both the orbitofrontal cortex and the amygdala
play parts in it.36 The orbitofrontal cortex plays an
important role in the regulation of emotional re-
sponses and behavior guided by predicted outcome,
through inhibition of amygdala.38
Our findings could also be seen in the context of the
‘dual brain pathology’ theory proposed by Tebartz van
Elst et al.9–11 The relatively diminished prefrontal
modulation of the anterior limbic network (e.g.
amygdala, thalamus, anterior striatum) and resulting
dysregulation of mood12 might also contribute to poor
decision-making and impulsivity in suicide attemp-
ters. The amygdala and orbitofrontal cortex cooperate
to encode the learning of goal-directed behavior,27,38
as the amygdala encodes the emotional significance of
external stimuli, and the orbitofrontal cortex uses
this information to adapt the behavior according
to the current needs of the individual. Right, but not
left, amygdala connectivity with bilateral orbitofron-
tal cortices is decreased during unconscious proces-
sing of behaviorally relevant stimuli.39 Increased
amygdala volumes have been reported in depressed
female10 and bipolar40,41 patients. One study reported
significantly larger amygdala volumes in patients
with first-episode versus recurrent major depres-
sion.42 The authors explained this finding in the
light of higher neural activity in the amygdala in the
first-episode group and longer exposure to antide-
pressant medication in the recurrent major depres-
sion group.42 It is hard to explain why suicidal
patients had larger right amygdala volumes than
non-suicidal patients in our analysis, and this finding
needs to be replicated.
One possible explanation for the finding that the
suicidal patients had more brain abnormalities than
the non-suicidal patients may be that suicidal
patients comprise a more severe phenotype of the
disorder, with an earlier age of onset and more prior
depressive episodes and longer disease duration. To
explore more about the effect of these confounding
variables on the brain regions of interest we exam-
ined, we performed correlation analyses to see
whether these confounding variables correlated with
the brain changes we reported, and none of the
correlations were statistically significant.
We did not find any evidence of changes in the
hippocampus of suicidal patients. Although the
hippocampus is one of the major limbic structures
implicated in the pathophysiology of mood disorders,
there is no consensus concerning a link between
hippocampal volume change and major depression.
Some studies report decreased hippocampal volumes,
whereas others report normal hippocampal volumes
in unipolar patients versus healthy subjects.43 Also,
there are reports that antidepressants may block or
even reverse hippocampal atrophy.43 The lack of
significant findings in our study for the hippocampus
may be due to previous antidepressant exposure,
which we did not control for.
There are several limitations of our analysis. The
severity of the illness was measured by comparing the
age at onset, number of episodes and the severity of
the affective episode at the time of MRI scans; and
there was no difference in illness severity for the
episode of depression at the time the MRI scans were
performed. However, the severity of the episode in
which the suicide attempt took place might be a more
important variable,16 and we did not have access to
that information. This also applies to their MRI scans
before or at the time of the suicide attempt. Our
analysis involved a relatively small sample size.
These findings are limited to women and need to be
replicated. Yet, the changes we observed in the
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orbitofrontal cortex and amygdala in suicidal patients
may be important in understanding the basis of the
suicidal behavior.
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